MusclePharm Corporation

MSLP

US6273352012

Investment Holding Companies

Market Closed - OTC Markets Other stock markets 20:28:56 03/04/2024 BST			5-day change	1st Jan Change
0.000001 ^USD	-99.92%		-.--%	-.--%

2023	Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	CI
2023	FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).	CI

MusclePharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2021

April 14, 2022 at 09:25 pm

MusclePharm Corporation reported earnings results for the fourth quarter ended December 31, 2021. For the fourth quarter, the company reported sales was USD 10.04 million compared to USD 15.13 million a year ago. Net loss was USD 6.78 million compared to net income of USD 2.82 million a year ago. Basic loss per share from continuing operations was USD 0.2 compared to basic earnings per share from continuing operations of USD 0.09 a year ago. Diluted loss per share from continuing operations was USD 0.2 compared to diluted earnings per share from continuing operations of USD 0.06 a year ago.

Latest news about MusclePharm Corporation

Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	18/10/23	CI
FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).	09/10/23	CI
Motion for Asset Sale Approved for MusclePharm Corporation	03/10/23	CI
FitLife Brands, Inc. entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.	26/09/23	CI
Stalking Horse Agreement Filed by MusclePharm Corporation	08/09/23	CI
Musclepharm Corporation Announces Resignation of Paul Karr as Director	31/08/23	CI
Second Amended Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	28/08/23	CI
First Amended Disclosure Statement Approved for MusclePharm Corporation	28/08/23	CI
Bidding Procedure Approved for MusclePharm Corporation	17/08/23	CI
Musclepharm Corporation Terminates Gary Shirshac as Chief Financial Officer	19/07/23	CI
First Amended Reorganization Plan and DIsclosure Statement Filed by MusclePharm Corporation	19/06/23	CI
Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	26/05/23	CI
Motion for Asset Sale Filed by MusclePharm Corporation	12/05/23	CI
First Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	10/05/23	CI
MusclePharm Corporation has withdrawn its IPO in the amount of $10 million.	16/04/23	CI
First Motion for Exclusivity Period Extension Filed by MusclePharm Corporation	10/04/23	CI
DIP Financing Approved for MusclePharm Corporation	08/03/23	CI
Amended DIP Financing Approved for MusclePharm Corporation	23/01/23	CI
Interim DIP Financing Approved for MusclePharm Corporation	09/01/23	CI
MusclePharm Corporation Filed for Bankruptcy	15/12/22	CI
MusclePharm Appoints Gary C. Shirshac as Interim CFO	29/09/22	MT
MusclePharm Corporation Appoints Gary C. Shirshac to Serve as Interim Chief Financial Officer	29/09/22	CI
MusclePharm Chief Financial Officer Eric Chin Resigns	23/08/22	MT
MusclePharm Corporation Announces Appointment of Eric Chin as Chief Financial Officer of the Company	28/07/22	CI
MusclePharm Corporation Announces Board Changes	28/07/22	CI

Chart MusclePharm Corporation

Duration

Period

More charts

Company Profile

MusclePharm Corporation is a United States company. The Company has no operation nor generated any revenue.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
MUSCLEPHARM CORPORATION	-.--%	33
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+161.77%	6.26B
CHURCHILL CAPITAL CORP VII	+2.33%	984M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+30.25%	851M
ARES ACQUISITION CORPORATION II	+1.72%	664M
E7 GROUP	+5.03%	648M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ADMIRAL ACQUISITION LIMITED	+12.78%	548M
CAPITOL INVESTMENT CORP. VII	-.--%	500M

Shell Companies